164 related articles for article (PubMed ID: 11895918)
1. Cyclooxygenase-2 induction by paclitaxel, docetaxel, and taxane analogues in human monocytes and murine macrophages: structure-activity relationships and their implications.
Cassidy PB; Moos PJ; Kelly RC; Fitzpatrick FA
Clin Cancer Res; 2002 Mar; 8(3):846-55. PubMed ID: 11895918
[TBL] [Abstract][Full Text] [Related]
2. Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme.
Moos PJ; Muskardin DT; Fitzpatrick FA
J Immunol; 1999 Jan; 162(1):467-73. PubMed ID: 9886421
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer.
Gallo D; Ferlini C; Distefano M; Cantelmo F; Gaggini C; Fattorossi A; Riva A; Bombardelli E; Proietti E; Mancuso S; Scambia G
Cancer Chemother Pharmacol; 2000; 45(2):127-32. PubMed ID: 10663627
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects toward human hematopoietic progenitor cells and tumor cell lines of paclitaxel, docetaxel, and newly developed analogues IDN5109, IDN5111, and IDN5127.
Ferlini C; Distefano M; Pierelli L; Bonanno G; Riva A; Bombardelli E; Ojima I; Mancuso S; Scambia G
Oncol Res; 1999; 11(10):471-8. PubMed ID: 10850888
[TBL] [Abstract][Full Text] [Related]
6. Taxanes: an overview of the pharmacokinetics and pharmacodynamics.
Vaishampayan U; Parchment RE; Jasti BR; Hussain M
Urology; 1999 Dec; 54(6A Suppl):22-9. PubMed ID: 10606281
[TBL] [Abstract][Full Text] [Related]
7. Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis.
Jordan MA; Ojima I; Rosas F; Distefano M; Wilson L; Scambia G; Ferlini C
Chem Biol; 2002 Jan; 9(1):93-101. PubMed ID: 11841942
[TBL] [Abstract][Full Text] [Related]
8. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
Sparano JA
Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
[TBL] [Abstract][Full Text] [Related]
9. Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis.
Moos PJ; Fitzpatrick FA
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3896-901. PubMed ID: 9520464
[TBL] [Abstract][Full Text] [Related]
10. Overcoming multidrug resistance in taxane chemotherapy.
Geney R; Ungureanu lM; Li D; Ojima I
Clin Chem Lab Med; 2002 Sep; 40(9):918-25. PubMed ID: 12435109
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and docetaxel enhance the metabolism of doxorubicin to toxic species in human myocardium.
Minotti G; Saponiero A; Licata S; Menna P; Calafiore AM; Teodori G; Gianni L
Clin Cancer Res; 2001 Jun; 7(6):1511-5. PubMed ID: 11410484
[TBL] [Abstract][Full Text] [Related]
12. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship of taxol inferring from docking taxol analogues to microtubule binding site.
Xiang F; Yu J; Yin R; Ma Y; Yu L
Z Naturforsch C J Biosci; 2009; 64(7-8):551-6. PubMed ID: 19791508
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of novel 2',2'-difluoro analogues of docetaxel.
Uoto K; Ohsuki S; Takenoshita H; Ishiyama T; Iimura S; Hirota Y; Mitsui I; Terasawa H; Soga T
Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1793-804. PubMed ID: 9396156
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of taxoids by human cytochromes P450: structure-activity relationship.
Monsarrat B; Royer I; Wright M; Cresteil T
Bull Cancer; 1997 Feb; 84(2):125-33. PubMed ID: 9180834
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3' and/or C-2 of taxotere (docetaxel).
Ojima I; Duclos O; Zucco M; Bissery MC; Combeau C; Vrignaud P; Riou JF; Lavelle F
J Med Chem; 1994 Aug; 37(16):2602-8. PubMed ID: 7914541
[TBL] [Abstract][Full Text] [Related]
17. The scientific rationale for developing taxoids.
Aapro M
Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
[TBL] [Abstract][Full Text] [Related]
18. Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors.
Ferlini C; Distefano M; Pignatelli F; Lin S; Riva A; Bombardelli E; Mancuso S; Ojima I; Scambia G
Br J Cancer; 2000 Dec; 83(12):1762-8. PubMed ID: 11104578
[TBL] [Abstract][Full Text] [Related]
19. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-gamma.
Endo T; Ogushi F; Sone S
J Immunol; 1996 Mar; 156(6):2240-6. PubMed ID: 8690914
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the structures of taxane derivatives and their microtubule polymerization activity.
Hidaka M; Koga T; Kiyota H; Horiguchi T; Shi QW; Hirose K; Uchida T
Biosci Biotechnol Biochem; 2012; 76(2):349-52. PubMed ID: 22313785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
